4//SEC Filing
Anika Therapeutics, Inc. 4
Accession 0001171843-16-008205
$ANIKCIK 0000898437operating
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:10 PM ET
Size
6.0 KB
Accession
0001171843-16-008205
Insider Transaction Report
Form 4
SHERWOOD CHARLES H
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-02-24+18,900→ 18,900 totalExercise: $39.69Exp: 2025-02-03→ Common Stock (18,900 underlying)
Footnotes (3)
- [F1]The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, February 3, 2015, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 2 and 3.
- [F2]On February 24, 2016, the Compensation Committee determined and certified that 112.5% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3.
- [F3]The stock options vest in four equal installments on the following dates: February 24, 2016, January 1, 2017, January 1, 2018 and January 1, 2019.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000898437
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:10 PM ET
- Size
- 6.0 KB